The Cooper Companies, Inc. (COO) is a Healthcare stock trading at $70.64 (as of 2026-09-03), with a market capitalization of $13.78B and a trailing P/E of 58.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
The Cooper Companies, Inc. develops, manufactures, and markets vision and women’s health products through two segments: CooperVision, which offers contact lenses, and CooperSurgical, which provides medical devices and related services. These products are supplied to health care professionals and patients across regions including the Americas, Europe, Middle East, Africa, and Asia Pacific.
Cooper makes contact lenses (spherical, toric, multifocal) for patients and family/women's health products for gynecologists and fertility clinics. The lens segment generates roughly twice the revenue of the surgical segment, and premium toric and multifocal products are the main growth lever.
Income is a recurring consumable: patients and clinics reorder lenses every 1 to 3 months, so revenue compounds with the aging myopia and presbyopia base rather than depending on a single product cycle.
| CooperVision | $0.7B |
| CooperSurgical | $0.4B |
| Other | $0.0B |
Business quality (Weak): Gross margin of 68% signals a strong moat in contact-lens formulation and regulatory approval, but the business quality grade is currently dragged to Weak by the one-time litigation hit and a P/E that sits well above the sector norm.
Valuation: At 52× earnings, COO trades 60% above the Medical Equipment average (33×).
| Price | $70.64 |
| Market Cap | $13.78B |
| P/E Ratio | 58.4 |
| EV / EBITDA | 18.4 |
| Price / Book | 1.67 |
| Price / Sales | 3.26 |
| FCF Yield | 3.1% |
| DCF Value (model) | $6.19 |
| DCF Upside vs Price | -91.2% |
| Revenue (TTM) | $4.09B |
| Net Margin | 9.2% |
| Revenue Growth (YoY) | 7.9% |
| EPS Growth (YoY) | -190.9% |
| FCF Growth (YoY) | 113.8% |
| Altman Z-Score | 3.47 (safe) |
| Piotroski F-Score | 6/9 (moderate) |
| Stock P/E | 58.4 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 30.3 |
| vs Sector | 170.5% |
| vs Industry | 92.5% |
| Top Institutional Holder | VANGUARD GROUP INC ($1.93B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 7 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Albert G. White |
| Employees | 16,000 |
| Country | US |
| IPO Date | 1983-01-21 |
Data as of 2026-09-03.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.